1
|
Affiliation(s)
- Brian Florenzo
- Department of Dermatology, University of Virginia School of Medicine, Charlottesville, Virginia
| | - Seth Martin
- Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia
| | - Arturo Saavedra
- Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia
| |
Collapse
|
2
|
Bharathi V, Goel M, Pombar XF, Nathan S, Okwuosa TM. Successful Triplet Pregnancy Post-Allogeneic Stem Cell Transplant in a Patient With Doxorubicin-Induced Cardiomyopathy. JACC Case Rep 2020; 2:987-990. [PMID: 34317399 PMCID: PMC8302090 DOI: 10.1016/j.jaccas.2020.04.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 04/03/2020] [Accepted: 04/09/2020] [Indexed: 11/17/2022]
Abstract
We report the unique case of a patient who recovered cardiac function despite a history of doxorubicin-induced cardiomyopathy, chest radiation therapy, high dose chemotherapy post-allogeneic stem cell transplant, and triplet pregnancy. Data are sparse on doxorubicin-induced cardiomyopathy in pregnant patients, calling for further studies to help formulate management or surveillance recommendations. (Level of Difficulty: Advanced.)
Collapse
Affiliation(s)
- Vanthana Bharathi
- Department of Internal Medicine, Division of Cardiovascular Diseases, Rush University Medical Center, Chicago, Illinois
| | - Mishita Goel
- Department of Internal Medicine, Division of Cardiovascular Diseases, Rush University Medical Center, Chicago, Illinois.,Department of Internal Medicine, Wayne State University, Detroit, Michigan
| | - Xavier F Pombar
- Department of Obstetrics & Gynecology, Rush University Medical Center, Chicago, Illinois
| | - Sunita Nathan
- Department of Internal Medicine, Division of Hematology/Oncology, Section of Bone Marrow Transplant and Cell therapy, Rush University Medical Center, Chicago, Illinois
| | - Tochukwu M Okwuosa
- Department of Internal Medicine, Division of Cardiovascular Diseases, Rush University Medical Center, Chicago, Illinois
| |
Collapse
|
3
|
Long J, Rajabi-Estarabadi A, Williams NM, Gurnani P, Maderal A, Elgart G, Nouri K. Recurrent systemic anaplastic large cell lymphoma: Rapid onset and resolution of cutaneous metastases. JAAD Case Rep 2020; 6:124-127. [PMID: 32016157 PMCID: PMC6992883 DOI: 10.1016/j.jdcr.2019.12.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Affiliation(s)
- Jun Long
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - Ali Rajabi-Estarabadi
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - Natalie M Williams
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - Pooja Gurnani
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - Andrea Maderal
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - George Elgart
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| | - Keyvan Nouri
- Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
| |
Collapse
|
4
|
McCoy WH, Otchere E, Musiek AC, Anadkat MJ. Granulomatous dermatitis as a postherpetic isotopic response in immunocompromised patients: A report of 5 cases. JAAD Case Rep 2018; 4:752-760. [PMID: 30246119 PMCID: PMC6141645 DOI: 10.1016/j.jdcr.2018.05.024] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Key Words
- AML, acute myelogenous leukemia
- CLL, chronic lymphocytic leukemia
- Chronic lymphocytic leukemia
- GA, granuloma annulare
- GD, granulomatous dermatitis
- HSV, herpes simplex virus
- MM, multiple myeloma
- PHIR, postherpetic isotopic response
- PHIR-GD, postherpetic isotopic response-granulomatous dermatitis
- PHN, postherpetic neuralgia
- SCT, stem cell transplant
- SLE, systemic lupus erythematous
- SS, Sjogren syndrome
- VZV, varicella zoster virus
- Wolf's isotopic response
- granuloma annulare
- granulomatous dermatitis
- immunocompromise
- immunocompromised district
- immunodeficiency
- immunosuppression
- isotopic response
- locus minoris resistentiae
- postherpetic isotopic response
Collapse
Affiliation(s)
- William H. McCoy
- Department of Medicine, Saint Louis, Missouri
- Division of Dermatology, Saint Louis, Missouri
- Washington University School of Medicine, Saint Louis, Missouri
- Correspondence to: William H. McCoy 4th, MD, PhD, Department of Medicine, Division of Dermatology, Washington University, 660 S Euclid, Campus Box 8123, St. Louis, MO 63110.
| | - Elaine Otchere
- Washington University School of Medicine, Saint Louis, Missouri
| | - Amy C. Musiek
- Department of Medicine, Saint Louis, Missouri
- Division of Dermatology, Saint Louis, Missouri
- Washington University School of Medicine, Saint Louis, Missouri
| | - Milan J. Anadkat
- Department of Medicine, Saint Louis, Missouri
- Division of Dermatology, Saint Louis, Missouri
- Washington University School of Medicine, Saint Louis, Missouri
| |
Collapse
|
5
|
Alikian M, Gale RP, Apperley JF, Foroni L. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia. Biomol Detect Quantif 2017; 11:4-20. [PMID: 28331814 PMCID: PMC5348117 DOI: 10.1016/j.bdq.2017.01.001] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/03/2016] [Revised: 12/28/2016] [Accepted: 01/18/2017] [Indexed: 12/25/2022]
Abstract
Chronic myeloid leukemia (CML) is the paradigm for targeted cancer therapy. RT-qPCR is the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy based on the reduction of blood or bone marrow BCR-ABL1. Some patients with CML and very low or undetectable levels of BCR-ABL1 transcripts can stop TKI-therapy without CML recurrence. However, about 60 percent of patients discontinuing TKI-therapy have rapid leukaemia recurrence. This has increased the need for more sensitive and specific techniques to measure residual CML cells. The clinical challenge is to determine when it is safe to stop TKI-therapy. In this review we describe and critically evaluate the current state of CML clinical management, different technologies used to monitor measurable residual disease (MRD) focus on comparingRT-qPCR and new methods entering clinical practice. We discuss advantages and disadvantages of new methods.
Collapse
Key Words
- ABL1, Abelson murine leukaemia virus
- ALL, acute lymphoblastic leukaemia
- AP, accelerated phase
- ARQ, armored RNA Quant
- ATP, adenosine triphosphate
- BC, blast crisis
- BCR, breakpoint cluster region
- BM, bone marrow
- BMT, bone marrow transplantation
- Bp, base pair
- CAP, College of American Pathology
- CES, capillary electrophoresis sequencing
- CML
- CML, chronic myeloid leukaemia
- CMR, complete molecular response/remission
- CP, chronic phase
- DESTINY, De-Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
- DNA, deoxyribonucleic acid
- EAC, Europe Against Cancer
- ELN, European Leukaemia Net
- EURO-SKI, European Stop Tyrosine Kinase Inhibitor Study
- GUSB, glucuronidase beta gene
- IC, inhibotory concentration
- IRIS, interferon and cytarabine versus STI571
- IS, International Scale
- InDels, insertions and deletions
- KDa, Kilo Dalton
- Kbp, Kilo Base Pairs
- LPC, leukemic progenitor cells
- LSC, leukemic stem cell
- LoD, limit of detection
- LoQ, limit of quantification
- M-bcr, major-breakpoint cluster region
- MMR, major molecular response/remission
- MR, deep molecular response/remission
- MRD
- MRD, minimal residual disease
- Mbp, mega base pair
- Molecular monitoring
- NCCN, National Comprehensive Cancer Network
- NEQAS, National External Quality Assessement Service
- NGS
- NGS, next generation sequencing
- NTC, No Template Control
- PB, Peripheral Blood
- PCR, Polymerase Chain Reaction
- PFS, Progression Free Survival
- Ph, Philadelpia
- Q-PCR, quantitative polymerase chain reaction
- QC, Quality Control
- RT, reverse transcription
- RT-dPCR, reverse transcription-digital polymerase chain reaction
- RT-qPCR, reverse transcription-quantitative polymerase chain reaction
- SCT, stem cell transplant
- SMRT, single-molecule real-time sequencing
- STIM, stop imatinib
- TKD, tyrosine kinase domain
- TKI, tyrosine kinase inhibitor
- WHO, World Health Organisation
- ZMW, zero-mode wave-guided
- allo-SCT, Allogeneic Stem Cell Transplantation
- cDNA, coding or complimentary DNA
- dMIQE, Minimum Information for Publication of Quantitative Digital PCR Experiments
- dPCR
- dPCR, digital polymerase chain reaction
- emPCR, emulsion PCR
- gDNA, genomic deoxyribonucleic acid
- m-bcr, minor-breakpoint cluster region
- mRNA, messenger RNA
- nM, manomolar
- μ-bcr, micro-breakpoint cluster region
- μg, microgram
- μl, microliter
Collapse
Affiliation(s)
- Mary Alikian
- Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK; Imperial Molecular Pathology, Imperial College Healthcare Trust, Hammersmith Hospital, London, UK
| | - Robert Peter Gale
- Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK
| | - Jane F Apperley
- Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK
| | - Letizia Foroni
- Centre for Haematology, Department of Medicine, Imperial College London Hammersmith Hospital, London UK
| |
Collapse
|